EUVIMEDEUVIMED entdecken
Crossref

Biologics in the Treatment of Eosinophilic Esophagitis: Ready for Use?

Diana L Snyder, Evan S Dellon

Clinical Gastroenterology and Hepatology · 2023

DOI: 10.1016/j.cgh.2023.07.025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2023. Verfasst von Diana L Snyder und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota. Electronic address: Snyder.diana@mayo.edu. Hauptthemen laut MEDLINE: Enteritis, Gastritis, Biological Products, Esophagitis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EnteritisGastritisBiological ProductsEsophagitisEosinophilic EsophagitisEosinophiliaHumans

Substanzen

Biological Products

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota. Electronic address: Snyder.diana@mayo.edu.
  • Center for Esophageal Diseases and Swallowing and Center for Gastrointestinal Biology and Disease, Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolin…

Zitieren

APA

Snyder, D. L., & Dellon, E. S. (2023). Biologics in the Treatment of Eosinophilic Esophagitis: Ready for Use?. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2023.07.025

Vancouver

Snyder DL, Dellon ES. Biologics in the Treatment of Eosinophilic Esophagitis: Ready for Use?. Clinical Gastroenterology and Hepatology. 2023. doi:10.1016/j.cgh.2023.07.025

BibTeX
@article{Snyder2023,
  author = {Snyder, Diana L and Dellon, Evan S},
  title = {Biologics in the Treatment of Eosinophilic Esophagitis: Ready for Use?},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2023},
  doi = {10.1016/j.cgh.2023.07.025}
}
Kostenlos starten →